4 Healthcare Stocks on Investing Radars Before Earnings

CareFusion (NYSE:CFN) will unveil its latest earnings on Thursday, May 3, 2012. The average analyst estimate is for profit of 45 cents per share, a rise of 7.1% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 46 cents. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. Analysts are projecting profit to rise by 8.5% compared to last year’s $1.79.

Last quarter, the company topped estimates by 0 cents, coming in at net income of 44 cents per share against a mean estimate of profit of 43 cents. The company fell in line with estimates in the first quarter. On average, analysts predict $889.7 million in revenue this quarter, a rise of 2.6% from the year-ago quarter. Analysts are forecasting total revenue of $3.64 billion for the year, a rise of 3.1% from last year’s revenue of $3.53 billion.

Cigna Corporation (NYSE:CI) will unveil its latest earnings on Thursday, May 3, 2012. The average analyst estimate is for profit of $1.28 per share, a decline of 6.6% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from $1.39. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.28 during the last month. Analysts are projecting profit to rise by 4% versus last year to $5.42.

The company is looking to break the streak of missing estimates in the past two quarters. Last quarter, it fell short of analyst expectations by reporting net income of $1.11 per share against an estimate of profit of $1.18 per share. The quarter before that, it missed forecasts by 2 cents. Analysts predict a rise of 24.5% in revenue from the year-earlier quarter to $6.71 billion.

Neurocrine Biosciences Inc. (NASDAQ:NBIX) will unveil its latest earnings on Wednesday, May 2, 2012. The average estimate of analysts is for the company to break even after the company reported net income of 5 cents per share in the year-earlier quarter. During the past three months, the average estimate has moved up from a loss of 5 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at breaking even during the last month. For the year, analysts are projecting a loss of 17 cents per share, a spike from profit of 67 cents last year.

Last quarter, the company beat estimates by one cent, coming in at net income of 2 cents per share against an estimate of profit of. The company also topped expectations in the third quarter of the last fiscal year. Analysts predict a decline of 13.3% in revenue from the year-earlier quarter to $10.8 million.

Cardinal Health, Inc. (NYSE:CAH) will unveil its latest earnings on Thursday, May 3, 2012. The average analyst estimate is for profit of 88 cents per share, a rise of 17.3% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 95 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 88 cents during the last month. Analysts are projecting profit to rise by 18.7% compared to last year’s $3.17.

Last quarter, the company beat estimates by 5 cents, coming in at net income of 81 cents a share versus the estimate of profit of 76 cents a share. It marked the fourth straight quarter of beating estimates. n average, analysts predict $26.71 billion in revenue this quarter, a rise of 2.5% from the year-ago quarter. Analysts are forecasting total revenue of $107.74 billion for the year, a rise of 5% from last year’s revenue of $102.64 billion.